CEL-SCI Corp (CVM.A)

CVM.A on American Stock Exchange

0.63USD
26 Dec 2014
Price Change (% chg)

$0.01 (+1.61%)
Prev Close
$0.62
Open
$0.59
Day's High
$0.65
Day's Low
$0.59
Volume
19,243
Avg. Vol
69,828
52-wk High
$1.89
52-wk Low
$0.54

CVM.A

Chart for CVM.A

About

CEL-SCI Corporation (CEL-SCI) is a research and development company focused on improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. The Company is involved in the research and development of immunotherapy products for the treatment of cancer and infectious... (more)
No analyst recommendations are available for CVM.A.

Overall

Beta: 0.84
Market Cap (Mil.): $57.55
Shares Outstanding (Mil.): 91.35
Dividend: --
Yield (%): --

Financials

  CVM.A Industry Sector
P/E (TTM): -- 159.35 38.84
EPS (TTM): -0.50 -- --
ROI: -234.19 -0.82 18.26
ROE: -332.30 -1.98 19.12
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $31.65 +0.23
Johnson & Johnson (JNJ.N) $105.06 +0.47
Novartis AG (NOVN.VX) CHF92.35 -1.20
Merck & Co., Inc. (MRK.N) $57.78 +0.32
Roche Holding Ltd. (ROG.VX) CHF270.10 -3.20
Sanofi SA (SASY.PA) €74.99 -0.65
Amgen, Inc. (AMGN.OQ) $163.46 +2.79
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $11.88 +0.46
Seattle Genetics, Inc. (SGEN.OQ) $32.00 +0.90

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks